4
80
P. Bojarová, S. J. Williams / Bioorg. Med. Chem. Lett. 19 (2009) 477–480
be advanced. The first explanation is that the crude enzyme prep-
arations used in this work as well as that for estrone sulfatase con-
tain at least two different sulfatase enzymes (or isozymes) that
possess different parameters of inactivation. Thus, the first fast
phase of inactivation reports on an enzyme possessing a high ki-
broad-scale use as small molecule tools in dissecting sulfatase-spe-
cific processes in complex biological systems. The generality of aryl
sulfamates as sulfatase inactivators suggests their potential applica-
tion in the treatment of sulfatase-related dysfunctions aside from
therapy of hormone-dependent breast cancer.
nact/K
i
value, whereas the second slower phase reports on a differ-
ent enzyme with a lower kinact/K value. An alternative explanation
i
Acknowledgments
for biphasic inactivation kinetics is that inactivation by 3-nitro-
phenyl sulfamate results in sulfamoylation of multiple enzyme res-
This work was supported by the Australian Research Council
and the Selby Foundation.
idues through two independent processes.1
2,14
Thus, one process
leads to the loss of enzyme activity by specific sulfamoylation of
the active-site FGly residue. The second process results in direct
sulfamoylation of other enzyme residues, possibly conserved ac-
tive-site nucleophiles such as Lys or His.14 This second process
leads to a non-specifically sulfamoylated enzyme with altered
parameters of inactivation that is then inactivated by specific sul-
famoylation of the active-site FGly.
Supplementary data
References and notes
It is also worthwhile commenting on the differences in the effi-
1
2
.
.
Hanson, S. R.; Best, M. D.; Wong, C.-H. Angew. Chem. Int. Ed. 2004, 43, 5736.
Bojarová, P.; Williams, S. J. Curr. Opin. Chem. Biol. 2008, 12, 573.
i
ciency of inactivation (in terms of the kinact/K ratio) seen for the
ꢀ
1
ꢀ1
four sulfatases. This value ranges from 480 to 0.038 s mM for
sulfatases from different origins, declining in the order
PaAtsA > snail > abalone (fast fraction) ꢂ limpet sulfatase. This cor-
relates well with the relative affinity of these sulfatases for potas-
3. Bond, C. S.; Clements, P. R.; Ashby, S. J.; Collyer, C. A.; Harrop, S. J.; Hopwood, J.
J.; Guss, J. M. Structure 1997, 5, 277.
Lukatela, G.; Krauss, N.; Theis, K.; Selmer, T.; Gieselmann, V.; von Figura, K.;
Saenger, W. Biochemistry 1998, 37, 3654.
Loft, K.; Williams, S. J. Complex carbohydrate modifying enzymes. In
Glycobiology; Sansom, C., Markman, O., Eds.; Scion: Bloxham: United
Kingdom, 2007; p 202.
Nussbaumer, P.; Billich, A. Med. Res. Rev. 2004, 24, 529.
Reed, M. J.; Purohit, A.; Woo, L. W. L.; Newman, S. P.; Potter, B. V. L. Endocr. Rev.
2005, 26, 171.
4
5
.
.
sium 4-nitrophenyl sulfate as reflected by the increasing K
from nanomolar (PaAtsA) to millimolar (abalone and limpet sulfat-
ases), Table 1. Therefore, the varying kinact/K ratio for these en-
m
value
6
7
.
.
i
zymes is likely related to differences in their affinity for the
nitrophenyl group. Indeed, closer inspection of these data reveals
a good correlation of inactivator K value with the K value for each
i m
enzyme. These data suggest that the ability of aryl sulfamates to
inactivate sulfatases is a common phenomenon.
Sulfatases mediate a wide variety of biological processes includ-
ing developmental cell signaling, hormone regulation, pathogenesis
and cellular degradation. Studies of these enzymes are limited by a
lack of specific reagents, especially inhibitors. This study demon-
strates that aryl sulfamates are time-dependent, active-site-direc-
ted inactivators of a range of sulfatases from various sources. The
8
.
.
Hoffman, J. A.; Badger, J. L.; Zhang, Y.; Huang, S. H.; Kim, K. S. Infect. Immun.
2000, 68, 5062.
9
Mougous, J. D.; Green, R. E.; Williams, S. J.; Brenner, S. E.; Bertozzi, C. R. Chem.
Biol. 2002, 9, 767.
10. Ratzka, A.; Vogel, H.; Kliebenstein, D. J.; Mitchell-Olds, T.; Kroymann, J. Proc.
Natl. Acad. Sci. USA 2002, 99, 11223.
11. Purohit, A.; Williams, G. J.; Howarth, N. M.; Potter, B. V. L.; Reed, M. J.
Biochemistry 1995, 34, 11508.
12. Woo, L. W. L.; Purohit, A.; Malini, B.; Reed, M. J.; Potter, B. V. L. Chem. Biol. 2000,
, 773.
3. Woo, L. W. L.; Purohit, A.; Reed, M. J.; Potter, B. V. L. J. Med. Chem. 1996, 39,
349.
7
1
1
14. Bojarová, P.; Denehy, E.; Walker, I.; Loft, K.; De Souza, D. P.; Woo, L. W. L.;
Potter, B. V. L.; McConville, M. J.; Williams, S. J. ChemBioChem 2008, 9, 613.
i
efficiency of inactivation (kinact/K ) for individual sulfatases corre-
1
5. Purohit, A.; Potter, B. V. L.; Parker, M. G.; Reed, M. J. Chem. Biol. Interact. 1998,
09, 183.
16. Römer, W.; Oettel, M.; Schwarz, S. Can. J. Physiol. Pharmacol. 1998, 76, 99.
lated with the K values for substrate hydrolysis. Thus, for sulfatases
m
1
able to catalyze the hydrolysis of a specific aryl sulfate, we anticipate
that the corresponding aryl sulfamate should act as an inhibitor. We
have already demonstrated that aryl sulfamates can be used as ac-
tive-site titrants for sulfatases,14 and there is great potential for their
1
7. Denehy, E.; White, J. M.; Williams, S. J. Chem. Commun. 2006, 314.
18. Shibata, H.; Yagi, T. Clin. Chim. Acta 1996, 251, 53.
19. Arnaldos, T. L.; Serrano, M. L.; Calderón, A. A.; Muñoz, R. Phytochem. Anal. 1999,
10, 171.